| 281/499 | US=21 / Biol/Mol Greenberger LM, Loganzo F. Destabilizing agents. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 227-58. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES DESESTABILIZADORES; DOLASTATINAS; CRIPTOFICINAS; HEMIASTERLINS; PHOMOPSIN; USILOXINS; DIAZONAMIDES; TUBULYSINS; VITILEVUAMIDE; TUBULINA; VINBLASTINA |
| 282/499 | US=21 / Biol/Mol Sackett DL. Antimicrotubule agents that bind covalently to tubulin. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 281-306. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES ANTIMICROTUBULO; TUBULINA; SULFIDRILA; CISTEINA; METAIS PESADOS; MERCURIO; CISPLATINA; LISINA |
| 283/499 | US=21 / Biol/Mol Horwitz SB, Fojo T. Microtubule stabilizing agents. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 307-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES ESTABILIZADORES DE MICROTUBULOS; ESTABILIZADORES DE MICROTUBULOS, AGENTES; PACLITAXEL; TAXOTERE; EPOTILONAS; DISCODERMOLIDE; MICROTUBULOS; TUBULINA |
| 284/499 | US=21 / Biol/Mol Takimoto CH, Beeram M. Microtubule stabilizing agents in clinical oncology. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 395-419. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. MICROTUBULO AGENTES ESTABILIZANTES EM ONCOLOGIA CLINICA; TAXANOS; PACLITAXEL; DOCETAXEL |
| 285/499 | US=21 / Biol/Mol Vereshchagina LA, Scharf O, Colevas AD. Investigational anticancer agents targeting the microtubule. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 421-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. INVESTIGACIONAIS AGENTES ANTICANCERIGENOS; SEGMENTACAO DOS MICROTUBULOS; EPOTILONA; DOLOSTATIN; COLCHICINA; AGENTES DE INVESTIGACAO |
| 286/499 | US=21 / Biol/Mol Carré M, Braguer D. Microtubule damaging agents and apoptosis. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 479-518. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES NOCIVOS MICROTUBULOS E APOPTOSE; APOPTOSE; MITOCONDRIAS; MICROTUBULOS; CELULA TUMORAL; DROGAS ANTI-CANCER; TAXANO; VINCA ALCALOIDES |
| 287/499 | US=21 / Biol/Mol Giavazzi R, Bonezzi K, Taraboletti G. Microtubule targeting agents and the tumor vasculature. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 519-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES DE MICROTUBULOS SEGMENTACAO EA VASCULARIZACAO DO TUMOR; INIBIDORES DA ANGIOGENESE; AGENTE DE RUPTURA VASCULAR; CELULAS ENDOTELIAIS; VASCULATURA TUMORAL; TERAPEUTICA DE COMBINACAO |
| 288/499 | US=28 / Biol/Mol Mendoza E, Burd R, Wachsberger P, Dicker AP. Normalization of tumor vasculature and improvement of radiation response by antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 311-21. ISBN 978-1-58829-870-6. ANGIOGENESE; AGENTES ANTI-ANGIOGENICOS; CANCER; CLINICO; PRE-CLINICO; NORMALIZACAO; TUMOR; RESPOSTA RADIACAO; TERAPIA DE RADIACAO; OXIGENACAO DO TUMOR; VASCULATURA |
| 289/499 | US=35 / Clín/Medica Harvey RA, Champe PC, Fisher BD. Agentes infecciosos não-convencionais. In: ___. Microbiologia ilustrada. 2 ed. Porto Alegre: Artmed, 2008. p. 327-30. ISBN 85-3631105-0. |
| 290/499 | US=35 / Biol/Mol Howley PM, DeMasi J. Infectious agents and cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 67-89. ISBN 978-1-4160-3703-3. CANCER; AGENTES INFECCIOSOS; VIRUS; PAPILOMAVIRUS HUMANO; VIRUS EPSTEIN BARR; VIRUS DA HEPATITE B; HERPESVIRUS; SARCOMA KAPOSI; RETROVIRUS HUMANO; HELICOBACTER PYLORI; PARASITAS |
| 291/499 | US=2 / Tórax Tsao AS. New chemotherapeutic agents in lung cancer. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 315-333. ISBN 978-1-4051-5112-2. AGENTES QUIMIOTERAPICOS NO CANCER DE PULMAO; CANCER DE PULMAO |
| 292/499 | US=23-C / Câncer Mano M, Machiels JP. Chemoradiation for rectal cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 357-73. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; CANCER DE RETAL; CANCER DE RETO; TRATAMENTO; QUIMIOIRRADIACAO; QUIMIOIRRADIACAO PRE-OPERATORIO; QUIMIOIRRADIACAO POS-OPERATORIO; RADIACAO PRE-OPERATORIO; CITOTOXICIDADE; AGENTES BIOLOGICOS; CAPECITABINA; OXALIPLATINA; TERAPIA ALVO |
| 293/499 | US=3 / Química Voet D, Voet JG, Pratt CW. Estrutura dos ácidos nucléicos. In: ___. Fundamentos de bioquímica: a vida em nível molecular. 2ª ed. Rio de Janeiro: Elsevier, 2008. p. 817-66. ISBN 85-3631347-4. HELICE DE DNA; ESTRUTURA DO DNA; INIBIDORES DE TOPOISOMERASES; AGENTES QUIMIOTERAPICOS; ESTRUTURA DOS ACIDOS NUCLEICOS; ACIDOS NUCLEICOS. FRACIONAMENTO; INTERACAO DNA-PROTEINA; ESTRUTURA DOS CROMOSSOMOS EUCARIOTICOS |
| 294/499 | US=30-A / Câncer Peters B. Dose adjustments of commonly used chemotherapeutic agents in hepatic failure and renal failure. In: Govindan R. The Washington manual of oncology. 2 nd. Philadelphia: J.B. Lippincott, 2008. p. 492-6. ISBN 978-1-5889-0323-0. AGENTES QUIMIOTERAPEUTICOS VULGARMENTE; INSUFICIENCIA HEPATICA; RENAL |
| 295/499 | US=30 / Clín/Medica Alterthum F. Origem e natureza química dos principais agentes antibacterianos. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 67-78. ISBN 85-7379981-1. |
| 296/499 | US=30 / Clín/Medica Mimica LMJ, Mendes CMF, Mimica IM. Controle laboratorial do tratamento das infecções bacterianas. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 93-9. ISBN 85-7379981-1. LABORATORIO DE MICROBIOLOGIA; AGENTES ANTIMICROBIANOS; TESTE DE SENSIBILIDADE; INTERPRETACAO DE RESULTADOS DE SENSIBILIDADE; METODOLOGIA |
| 297/499 | US=30 / Clín/Medica Gompertz OF, Gambale W, Paula CR, Corrêa B, Rivera ING. Características gerais das micoses. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 493-502. ISBN 85-7379981-1. MICOSES. CARACTERISTICAS; MECANISMOS DE DEFESA; FATORES DE VIRULENCIA; PATOGENESE; DIAGNOSTICO; AGENTES ANTIFUNGICOS |
| 298/499 | US=30 / Clín/Medica Rácz ML, Menck CFM. Propriedades gerais dos vírus. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 537-42. ISBN 85-7379981-1. |
| 299/499 | US=39 / Câncer Daniels TR, Neacato IL, Helguera G, Penichet ML. Targeting the transferrin receptor to overcome resistance to anti-cancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 13-27. ISBN 978-1-58829-989-5. RECEPTORES-ALVO; TRANSFERRINA; AGENTES ANTICANCERIGENOS; QUIMIORRESISTENCIA |
| 300/499 | US=39 / Câncer Yoshida T, Sakai T. Agents that regulate DR5 and sensitivity to TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 41-9. ISBN 978-1-58829-989-5. |